However, in TN subtype tumors, we observed that patients with lower Maspin expression had a worse prognosis for cancer specific survival (Cytoplasmic marking: OS p = 0.043; DFS p = 0.06) (Fig. 4). This evidence concerns the gene SERPINB5 and cancer.